Achilles Therapeutics plc (ACHL)
NASDAQ: ACHL · Real-Time Price · USD
1.045
+0.005 (0.48%)
At close: Nov 7, 2024, 4:00 PM
1.031
-0.014 (-1.34%)
After-hours: Nov 7, 2024, 5:36 PM EST
Achilles Therapeutics Market Cap
Achilles Therapeutics has a market cap or net worth of $42.94 million as of November 7, 2024. Its market cap has increased by 15.25% in one year.
Market Cap
42.94M
Enterprise Value
-47.71M
1-Year Change
15.25%
Ranking
Category
Stock Price
$1.05
Market Cap Chart
Since the IPO on March 31, 2021, Achilles Therapeutics's market cap has decreased from $731.19M to $42.94M, a decrease of -94.13%. That is a compound annual growth rate of -54.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2024 | 42.94M | 18.43% |
| Dec 29, 2023 | 36.26M | -1.60% |
| Dec 30, 2022 | 36.84M | -81.89% |
| Dec 31, 2021 | 203.42M | -72.18% |
| Mar 31, 2021 | 731.19M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immix Biopharma | 43.37M |
| Exagen | 42.94M |
| LakeShore Biopharma | 42.93M |
| CollPlant Biotechnologies | 42.50M |
| Rallybio | 42.32M |
| IceCure Medical | 42.09M |
| DURECT | 41.90M |
| ProPhase Labs | 41.78M |